• Pioglitazone: PPARγ Agonist Workflows for Inflammation & Met

  2026-06-29

  Leverage Pioglitazone as a precision PPARγ agonist to model macrophage polarization, dissect metabolic and inflammatory mechanisms, and optimize translational research workflows. Discover actionable protocol enhancements and troubleshooting strategies rooted in recent mechanistic breakthroughs and cross-domain applications.

• MAPK10-Mediated KRT16 Degradation Suppresses NSCLC Metastasi

  2026-06-29

  This study reveals that mitogen-activated protein kinase 10 (MAPK10) suppresses non-small cell lung cancer (NSCLC) metastasis by promoting the phosphorylation-dependent ubiquitination and degradation of keratin 16 (KRT16). The mechanistic insight into the MAPK10/KRT16/RNF213 axis provides a new foundation for targeted biomarker development and informs strategies for personalized NSCLC therapy.

• Optimizing Sulfaphenazole Derivatives for TB: Reducing CYP2C

  2026-06-28

  This study systematically optimized sulfonamide derivatives of sulfaphenazole to retain potent antimycobacterial activity against Mycobacterium tuberculosis while minimizing inhibition of the human CYP2C9 enzyme. The findings provide a rational path toward safer, more effective TB therapies that reduce drug-drug interaction risks.

• Functional Genomic Screens Reveal Mechanisms of Drug-Induced

  2026-06-27

  Honeywell et al. introduce MEDUSA, a simulation-assisted approach for dissecting drug-induced cell death mechanisms, addressing the confounding effects of growth rate variability in chemo-genetic screens. This methodology clarifies genetic dependencies of lethality, enabling more precise identification of apoptosis and non-apoptotic pathways with direct implications for cancer and cell death research.

• DiscoveryProbe FDA-approved Drug Library: Applied High-Throu

  2026-06-26

  The DiscoveryProbe FDA-approved Drug Library empowers rapid drug repositioning and target identification by providing 2,320 clinically validated compounds in ready-to-use formats. This article delivers actionable workflows, troubleshooting tactics, and translational insights, highlighting how this library accelerates experimental discovery across oncology and beyond.

• (S)-Mephenytoin and CYP2C19: Redefining Human-Relevant Drug

  2026-06-26

  (S)-Mephenytoin is a benchmark CYP2C19 substrate that is critical for modern pharmacokinetic studies. This article uniquely examines its performance and interpretation in advanced human-derived intestinal organoid models, providing deeper guidance for researchers seeking translationally relevant drug metabolism data.

• Tetracycline: Broad-Spectrum Polyketide Antibiotic in Modern

  2026-06-25

  APExBIO’s high-purity Tetracycline empowers advanced microbiological and translational research by enabling precise antibiotic selection, ribosomal function analysis, and novel stress modeling. This guide translates recent mechanistic discoveries into actionable protocols and troubleshooting strategies for reliable, reproducible results.

• LY2886721: Advanced BACE1 Inhibition for Amyloid Pathology R

  2026-06-25

  Explore how LY2886721, a potent BACE inhibitor, enables nuanced amyloid beta reduction without compromising synaptic transmission. This article offers a deeper methodological perspective and practical assay guidance beyond the standard narrative.

• Tamoxifen as a Selective Estrogen Receptor Modulator in Rese

  2026-06-24

  Tamoxifen stands at the crossroads of cancer biology and genetic engineering, offering robust control over estrogen receptor pathways and precision in CreER-mediated gene knockout models. This article details practical workflows, protocol enhancements, and troubleshooting tips for maximizing Tamoxifen’s research value, with evidence-based insights from recent mitochondrial metabolism studies.

• AMG 487: CXCR3 Antagonist for Precision Macrophage Modulatio

  2026-06-23

  AMG 487 stands out as a nanomolar-potency CXCR3 antagonist, enabling precise manipulation of macrophage polarization and autophagy in both inflammatory and homeostatic settings. Its unique utility in dissecting CXCL10-CXCR3 axis signaling is shaping next-generation inflammation, cancer, and lung injury models.

• Peptidisc-Assisted Multimerization for Advanced Nanobody Eng

  2026-06-23

  Chen and Duong van Hoa present a peptidisc-based strategy for generating multimeric and multispecific nanobody proteins, achieving enhanced binding and functional versatility. Their approach leverages hydrophobic clustering stabilized by amphipathic peptidiscs, expanding options for protein engineering and detection.

• Adefovir (SKU C6629): Reliable Antiviral for HBV Lab Studies

  2026-06-22

  This scenario-driven guide explores how Adefovir (SKU C6629) addresses key challenges in hepatitis B virus research and transporter assays. By referencing real bench scenarios, quantitative performance data, and best-practice recommendations, it demonstrates why Adefovir from APExBIO is a preferred choice for reproducible, selective, and cost-effective workflows.

• (R,S)-Anatabine: Optimizing Soluble Aβ Reduction in Alzheime

  2026-06-22

  (R,S)-Anatabine, supplied by APExBIO, enables precise targeting of amyloid-beta production and neuroinflammation in both cell-based and animal Alzheimer’s disease models. This guide delivers workflow enhancements, troubleshooting insights, and data-driven parameters to maximize reproducibility and mechanistic clarity.

• GM 6001 (Galardin) in Advanced Extracellular Matrix Research

  2026-06-21

  GM 6001 (Galardin) empowers researchers to dissect matrix metalloproteinase-driven processes from cancer progression to tissue repair. Discover advanced workflows, troubleshooting strategies, and translational insights that set this broad-spectrum inhibitor apart for rigorous extracellular matrix and signaling studies.

• ML133 HCl in Translational Cardiovascular Research: Mechanis

  2026-06-20

  This article explores the mechanistic underpinnings and strategic utility of ML133 HCl, a selective Kir2.1 potassium channel inhibitor, for translational researchers probing pulmonary artery smooth muscle cell proliferation and vascular remodeling. We bridge recent mechanistic validation, competitive landscape, and translational insights to guide strategic research decisions.

466 records 14/32 page Previous Next First page 上5页 1112131415 下5页 Last page